





Vaginal Microbiome Screen
Understand your risk of vaginal infections like thrush or BV, STIs, fertility implications, and other gynae health complications using a non-invasive at-home tampon screen.
- Non-invasive, at-home screen
- Personalised, actionable results
- Access to prescription treatments to your door
Frequently bought together
Who is this service for?
If you have recurrent infections
If you have recurrent infections
Our Diagnostic Tampon can check for infection-causing microbes and fungi, as well as your levels of protective, good bacteria.
We suggest screening 2-4 times per year or when symptoms appearIf you have fertility concerns
If you have fertility concerns
The vaginal microbiome plays a vital role in reproductive health, and disruptions can impact fertility.
We suggest a one-off screen to identify all treatable issueIf you are in (peri)menopause
If you are in (peri)menopause
The vaginal microbiome changes during perimenopause, increasing the risk of infections and vaginal dryness.
We suggest two screens per year to maintain a healthy and well-balanced vaginal environmentDetect bacteria that can cause vaginal infections like thrush & BV
Understand if you have an STI or are at a higher risk of UTIs
Determine if your IVF cycle is less likely to be successful
Check for fertility-blocking microbes
Choose a screen that works for you
Microbiome + STI + HPV Screen
£277
What we test for:
Lactobacilli
Common BV related bacteria
Candida
Mycoplasma hominis
Ureaplasma
Gonorrhea
Chlamydia
Trichomoniasis
Mycoplasma genitalium
HPV16
HPV18
12 other high-risk HPV types
Microbiome + STI Screen
£188
What we test for:
Chlamydia
Gonorrhea
Trichomoniasis
Mycoplasma genitalium
Lactobacilli
Common BV related bacteria
Candida
Mycoplasma hominis
Ureaplasma
Microbiome Screen
What we test for:
Lactobacilli
Common BV related bacteria
Candida
Mycoplasma hominis
Mycoplasma genitalium
Ureaplasma
Wait, the vaginal micro-what?
Like your gut, your vagina is home to billions of bacteria (some good, some bad). These make up your vaginal microbiome. When it doesn’t contain enough good bacteria, you’re at greater risk of vaginal dryness, fertility challenges, as well as infections like STIs, thrush and BV.
Which pathogens do we test for?
With cutting-edge PCR technology for unparalleled accuracy, Daye tampons collect more vaginal fluid than a standard swab and cover the whole vaginal canal.
Lactobacilli
Good bacteria in your vaginal microbiome.
Anaerobic bacteria
Cause infections like bacterial vaginosis (BV).
Candida
Candida is a fungus which affects 75% of women.
Mycoplasma/ Ureaplasma
According to studies, can affect fertility.
Chlamydia
A very common STI caused by a bacterial infection.
*Only available with the STI Screen
Gonorrhoea
An STI that can affect both men and women.
*Only available with the STI Screen
Trichomoniasis
One of the most common STIs worldwide.
*Only available with the STI Screen
HPV screening
Detects the presence of high risk human papillomavirus strains.
*Only available with the HPV Screen
Herpes Type I & II
Can potentially infect another person.
*Only available with the STI Screen
What is included with every screening?
Order your test & get a kit delivered to your door
The kit will arrive at your doorstep in a discreet package. No more awkward queuing in clinic waiting rooms.

Collect and send off your sample to our accredited lab
Activate your kit with your unique code, complete a short symptom questionnaire, and send your sample - we'll handle the rest.

Get detailed, actionable results.
We never want to leave you stuck with a set of confusing or potentially troubling results. If you test positive for an STI, one of our sexual health nurses will provide a free consultation.

Connect with vetted specialists & get prescription treatments to your doorstep.
After the screening, you can set up virtual consultations with our vetted sexual health, fertility, and menopause experts. You can also get treatments discreetly delivered to your door.

Discover simple changes you can implement to take control of your health
Every report includes science-backed, personalised insights into lifestyle changes you can adopt to further enhance your health.

Be your own health hero
Got an infection that keeps coming back?
Got an infection that keeps coming back?
Mainstream treatments for BV and thrush can put us at a higher risk of recurrent infections.
Learn moreOwn your fertility journey.
Own your fertility journey.
A healthy microbiome is vital for successful fertilisation, implantation, and embryo development.
Learn moreWorried about STIs?
Worried about STIs?
As many as 70% of female STIs are asymptomatic, making proactive screening essential.
Learn moreSee our Founder’s results!
Wondering what we test for, and what results look like? Enter your email below and Valentina, our Founder, will send you her screening report.
By entering your email above you agree to receive marketing emails and promotions from Daye.

Your data is for your eyes only
Protecting your privacy is the least we can do
Frequently asked questions
Still have questions? Read all of our FAQs.
Relevant Research
Diagnosis of bacterial vaginosis on self-collected vaginal tampon specimens
2002 • P D J Sturm, P Moodley, G Nzimande
Results of the tampon and vaginal smears showed excellent agreement for both observers (Spearman >0.80). The overall sensitivity and specificity were 91.7% (95% CI: 81.6-96.5) and 79.3% (95% CI: 67.2-87.8), respectively, using the Amsel criteria as reference standard. The tampon provides a specimen for the combined diagnosis of non-ulcerative STIs and BV.
A Self-Administered Technique for the Detection of Sexually Transmitted Diseases in Remote Communities
1997 • Sepehr N. Tabrizi, Barbara Paterson, Christopher K. Fairley, Francis J. Bowden, Suzanne M. Garland
The detection of each organism was significantly greater by PCR in tampon-collected samples than by routine conventional methods (P < .01).
Pilot study of the utility and acceptability of tampon sampling for the diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis infections by duplex realtime polymerase chain reaction in United Kingdom sex workers
2010 • P T Kimmitt, S N Tabrizi, M Crosatti, S M Garland Frcpa, P C Schober, K Rajakumar, C A Chapman
Besides near-universal acceptability of tampon sampling, the tampon sampling–PCR approach described in this study appeared to have enhanced sensitivity compared with conventional testing.
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
2011 • Rebecca M. Brotman
Vaginal bacterial communities are thought to help prevent sexually transmitted infections. Bacterial vaginosis (BV) is a common clinical syndrome in which the protective lactic acid-producing bacteria (mainly species of the Lactobacillus genus) are supplanted by a diverse array of anaerobic bacteria. Epidemiologically, BV has been shown to be an independent risk factor for adverse outcomes including pre-term birth, development of pelvic inflammatory disease, and acquisition of sexually transmitted infections. Longitudinal studies of the vaginal microbiome using molecular techniques such as 16S ribosomal DNA analysis may lead to interventions that shift the vaginal microbiota toward more protective states.
The Vaginal Microenvironment: The Physiologic Role of Lactobacilli
2018 • Emmanuel Amabebe, Dilly O. C. Anumba
Lactobacilli and their antimicrobial and anti-inflammatory products along with components of the epithelial mucosal barrier provide an effective first-line defence against invading pathogens including bacterial vaginosis, aerobic vaginitis-associated bacteria, viruses, fungi and protozoa. An optimal host-microbial interaction is required for the maintenance of eubiosis and vaginal health.
The role of Escherichia coli in reproductive health
2017 • P Cools
Vaginal dysbiosis has been associated with increased susceptibility to and transmission of HIV and other sexually transmitted infections and increased risk of pelvic inflammatory disease, pre-term birth and maternal and neonatal infections.
Pregnancy's Stronghold on the Vaginal Microbiome
2014 • Marina R. S. Walther-António, Patricio Jeraldo, Margret E. Berg Miller, Carl J. Yeoman, Karen E. Nelson, Brenda A. Wilson, Bryan A. White, Nicholas Chia, Douglas J. Creedon
Our analyses indicate normal pregnancy is characterised by a microbiome that has low diversity and high stability. While Lactobacillus species strongly dominate the vaginal environment during pregnancy across the two studied ethnicities, observed differences between the longitudinal dynamics of the analysed populations may contribute to divergent risk for pregnancy complications. This helps establish a baseline for investigating the role of the microbiome in complications of pregnancy such as pre-term labour and pre-term delivery.
The vaginal microbiome as a tool to predict IVF success
2020 • Sam Schoenmakers, Joop Laven
The vaginal composition prior to the start of hormonal treatment for ART seems to be predictive of in vitro fertilization/in vitro fertilization-intracytoplasmic sperm injection (IVF/IVF-ICSI) outcome, with mainly a highly negative predictive value.
Early pregnancy vaginal microbiome trends and pre-term birth
2017 • Molly J. Stout, Yanjiao Zhou, Kristine M. Wylie, Phillip I. Tarr, George A. Macones, Methodius G. Tuuli
In a predominantly African-American population, a significant decrease of vaginal microbial community richness and diversity is associated with pre-term birth. The timing of this suppression appears early in pregnancy, between the first and second trimesters, suggesting that early gestation may be an ecologically important time for events that ordain subsequent term and pre-term birth outcomes.
The role of the vaginal microbiome in gynaecological cancer
2017 • M Champer, A M Wong, J Champer, I L Brito, P W Messer, J Y Hou, J D Wright
Human microbiome research has shown commensal bacteria to be a major factor in both wellness and disease pathogenesis. Interest in the microbiome has recently expanded beyond the gut to include a multitude of other organ systems for which the microbiome may have health implications. Here, we review the role of the vaginal microbiome in health and disease, with a particular focus on gynecologic malignancies. Further, we suggest that it may be possible to expand the use of probiotics in the treatment of gynaecological cancers.
Association between polycystic ovary syndrome and the vaginal microbiome: A case-control study
2020 • Xiang Hong, Pengfei Qin, Kaiping Huang, Xiaoling Ding, Jun Ma, Yan Xuan, Xiaoyue Zhu, Danhong Peng, Bei Wang
There was significant difference in vaginal bacterial structures between PCOS and healthy control women. The relative abundance of Lactobacillus crispatus in the PCOS group was significantly lower than controls (P = .001), and the relative abundance of Mycoplasma and Prevotella was higher than controls (P < .001, P = .002, respectively). The Mycoplasma genus could be a potential biomarker for PCOS screening, as ROC analysis showed that the area under the curve (AUC) for the relative abundance of Mycoplasma was 0.958 (95% CI: 0.901-0.999).
Menstrual Tampons Are Reliable and Acceptable Tools to Self-Collect Vaginal Microbiome Samples
2023 • Florence Turner, Josephine Drury, Dharani K Hapangama, Nicola Tempest
Many women report embarrassment as the cause for their avoidance of routine gynaecological screening appointments. Methods of self-collection of bio samples would perhaps encourage women to participate in routine screening programs. The vaginal microbiome plays a key role in women's health and reproductive function. Microbial disturbances can result in the loss of lactobacillus dominance, also known as dysbiosis, associated with an increased risk of contracting sexually transmitted infections (STIs), pregnancy complications and infertility. All (100%) of volunteers were happy to provide a tampon as a sample for testing. The findings from this study show that tampons and LVSs were comparable when analysing the vaginal microbiome, with potential superiority of the tampon with regard to patient acceptability.






